Acadia Receives FDA Priority Review For Parkinson's Drug
November 03, 2015 at 12:25 PM EST
Acadia receives FDA Priority Review for Parkinson's Drug; Shares closed up 15% yesterday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.